UL

Myriad Genetics buys Rules-Based Medicine

Friday, April 29, 2011 01:20 PM

A Utah-based biotech company, Myriad Genetics, will buy Rules-Based Medicine for $80 million, according to The Salt Lake Tribune.

More... »


Advanced Cell Technology receives IRB approval for SMD/AMD studies at UCLA

Friday, April 29, 2011 10:57 AM

Massachusetts-based Advanced Cell Technology, a biotechnology company focused on developing regenerative medicine, reports that the Jules Stein Eye Institute at the University of California, Los Angeles (UCLA) has received institutional review board (IRB) approval to be a site for its phase I/II human clinical trials for Stargardt's Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (Dry AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

More... »


CEO of the Multiple Myeloma Research Foundation makes the TIME 100 list

Friday, April 22, 2011 12:19 PM

TIME has named Kathy Giusti, Founder and CEO of the Multiple Myeloma Research Foundation (MMRF), to the 2011 TIME 100, the magazine’s annual list of the 100 most influential people in the world.

More... »

Duke University and the Wallace H. Coulter Foundation create $20 million endowment

Thursday, April 21, 2011 12:41 PM

Duke University and the Wallace H. Coulter Foundation have created a $20 million endowment to foster a research collaboration between bioengineers and clinicians with the goal of developing new technologies to improve patient care.

More... »

Anulex Techonologies will layoff workers

Wednesday, April 20, 2011 11:28 AM

Minnesota-based Anulex Techonologies will layoff workers after receiving a warning letter from the FDA in February, 2011, according to Fierce Medical Devices

More... »

Regulus Therapeutics appoints Neil W. Gibson as CSO

Monday, April 18, 2011 01:09 PM

Regulus Therapeutics, a biopharmaceutical company that discovers and develops new medicines targeting microRNAs, has appointed Neil Gibson, Ph.D., as its chief scientific officer. 

More... »

Multiple Myeloma Research Foundation’s Edward Jay Phillips deceased

Monday, April 11, 2011 12:31 PM

The Multiple Myeloma Research Foundation (MMRF) mourns the loss of board member Edward (“Eddie”) Jay Phillips, who, on April 8, 2011 died of multiple myeloma. Phillips, son of "Dear Abby" and creator of Belvedere Vodka, had battled multiple myeloma for nine years.

More... »

CRO Beardsworth poised to move ahead with founder's vision

Tuesday, April 5, 2011 09:00 AM

Senior management of Beardsworth Consulting say they will continue to carry out the vision of company founder, president and CEO Donna E. Beardsworth, who died suddenly March 22 at age 54.

More... »

Condolences

Thursday, March 31, 2011 01:37 PM

We deeply regret informing our readers of the recent deaths of Thomas Littlejohn, M.D. and Donna Beardsworth. Both Tommy and Donna devoted their professional lives to serving the clinical research enterprise:

More... »

Spaulding device automates trials

Tuesday, March 22, 2011 12:05 PM

Spaulding Clinical Research has received 510k approval for its proprietary ECG device platform, Spaulding IQ, according to Fierce BiotechIT.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs